Drug Induced Liver Injury - A Medicinal Chemist's Perspective 

This talk provides a medicinal chemist's perspective on the current understanding of DILI mechanisms, highlight cutting-edge assay developments for a holistic assessment, and discuss strategies for predicting DILI risks. This session aims to equip medicinal chemists with working knowledge to manage DILI risks on their programs.
00:22 Introduction
02:04 Ice-breaker questions
08:27 Presentation
39:55 Q&A
Presented by Anh Tran, Ph.D. Principal Scientist and Medicinal Chemistry Team Leader at Amgen with host Dennis Koester, Director of Industry Research and Relations, Drug Hunter
Presented on June 6, 2024, as a Drug Hunter Flash Talk.
Sign up for future sessions here: drughunter.com...